CI Investments Inc’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,757
| Closed | -$94K | – | 1288 |
|
|
2025
Q1 | $94K | Sell |
2,757
-12
| -0.4% | -$409 | ﹤0.01% | 921 |
|
|
2024
Q4 | $109K | Buy |
2,769
+466
| +20% | +$18.3K | ﹤0.01% | 909 |
|
|
2024
Q3 | $108K | Buy |
2,303
+18
| +0.8% | +$844 | ﹤0.01% | 830 |
|
|
2024
Q2 | $123K | Buy |
2,285
+576
| +34% | +$31K | ﹤0.01% | 755 |
|
|
2024
Q1 | $116K | Buy |
1,709
+1
| +0.1% | +$68 | ﹤0.01% | 850 |
|
|
2023
Q4 | $107K | Sell |
1,708
-155
| -8% | -$9.71K | ﹤0.01% | 813 |
|
|
2023
Q3 | $85K | Sell |
1,863
-56
| -3% | -$2.56K | ﹤0.01% | 854 |
|
|
2023
Q2 | $108K | Sell |
1,919
-230
| -11% | -$12.9K | ﹤0.01% | 770 |
|
|
2023
Q1 | $97K | Sell |
2,149
-27
| -1% | -$1.22K | ﹤0.01% | 747 |
|
|
2022
Q4 | $88K | Buy |
2,176
+1,820
| +511% | +$73.6K | ﹤0.01% | 777 |
|
|
2022
Q3 | $23K | Sell |
356
-27
| -7% | -$1.74K | ﹤0.01% | 996 |
|
|
2022
Q2 | $23K | Buy |
383
+14
| +4% | +$841 | ﹤0.01% | 951 |
|
|
2022
Q1 | $23K | Buy |
369
+26
| +8% | +$1.62K | ﹤0.01% | 1040 |
|
|
2021
Q4 | $26K | Buy |
343
+72
| +27% | +$5.46K | ﹤0.01% | 1067 |
|
|
2021
Q3 | $30K | Buy |
+271
| New | +$30K | ﹤0.01% | 1025 |
|